Yuhan's 10 medicines break 10-billion mark in 2007 sales
Yuhan Corporation's ten flagship products exceeded 10-billion sales last year, propelled by strong demand in related sectors.
Of these items, Yuhan's new drug Revanex (revaprazan) surpassed a 10 billion mark in less than one year after launching. Revanex is expected to be one of Yuhan's le...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
